GYEMSZI - MOB

Pathology Oncology Research - Kapcsolódó tételek

51.			An effective, direct immunomagnetic prodecure for purging acute lymphoblastic leukemia cells from human bone marrow
52.			Embryotoxicity and teratogenicity of some derivatives of chloroethylaminophenylacetic acid
53.			Eosinophils and mast cells in Helicobacter pylori infected gastric mucosa
54.			Erythema gyratum repens an immunological paraneoplastic dermatosis
55.			Experimental study on the carcinogenicity of the cytostatic drug Ftorafur (Tegafur)
56.			Expression of invasion markers CD44v6/v3, NM23 and MMP2 in laryngeal and hypopharyngeal carcinoma
57.			The expression of lysosomal proteinases and their inhibitors in breast cancer: possible relationship to prognosis of the disease
58.			The facultative stem cell: a new star in liver pathology
59.			Fibrinolytic activity of earthworms extract (G-90) on lysis of fibrin clots originated from the venous blood of patients with malignant tumors
60.			Fibroblast enhancement of tumor invasion in a tumor-host interface recapitulated in-vitro
61.			Giant cell hepatitis in adults
62.			Giant mitochondria as possible bioindicators of environmental injuries in fish liver
63.			Glottic cancer of the free margin and ventricular surface of vocal cord
64.			Granular cell variant of atypical fibroxanthoma
65.			Granulomatous hepatitis preceding Hodgkin's disease : case-report and review on differential diagnosis
66.			Haptoglobin-related protein as a serum marker in malignant lymphoma
67.			Heterogeneous expression of invasive and metastatic properties in a prostate tumor model
68.			Histidine decarboxylase in peripheral lymphocytes of healthy individuals and chronic lymphoid leukemia patients
69.			Histiocytic and T-cell rich B-cell lymphoma (TCRBCL) of the stomach
70.			HLA-DR2 frequency increase in severe aplastic anemia patients is mainly attributed to the prevalence of DR15 subtype
71.			The HNK-1 carbohydrate epitope and the human eye in health and disease
72.			Immune responses to the MUC1 mucin
73.			Immunohistochemical and ultrastructural analysis of a mammary cystic hypersecretory carcinoma
74.			Immunohistochemical characterization of antioxidant enzymes in human breast cancer
75.			Immunohistochemical expression of N-ras oncogene is a late event in head and neck carcinomas
76.			Immunohistophatological characterization of spontaneous metastases in a human lung mucoepidermoid adenocarcinoma (HLMC) xenograft
77.			Immunologic profile of patients suffering from herpes simplex virus (HSV)-associated oral lesions treated with natural human interferon alpha (Egiferon)
78.			The impact of axillary lymphadenopathy on further treatment in breast cancer? : a model for clinical staging
79.			An in vitro model for studying mechanisms underlying synoviocyte-mediated cartilage invasion in rheumatoid arthritis
80.			Inflammatory and physiological roles of chemokines
81.			Intracerebral human lymphoma - an experimental model
82.			Intravenous leiomyomatosis of the uterus
83.			Lack of correlation between survival and allele loss on chromosome 7q31-32 in primary breast cancer
84.			Leiomyoma of the ciliary body and hemangiopericytoma of the choroid
85.			Leiomyoma of the urinary bladder
86.			Lipoma of the uterus
87.			Low serum pancreatitis-associated protein does not exclude complications in mild acute pancreatitis
88.			Lower cancer risk in medium high radon
89.			Lung cancer: a bronchoscopic approach
90.			Lymph node reaction to cancer : immunohistochemical and ultrastructural study
91.			Malignant mixed mullerian tumor fo the extra-genital coelomic epithelium: report of two cases
92.			Malignant transformation alters intracellular trafficking of lysosomal cathepsin D in human breast epithelial cells
93.			Mapping the location of prognostically significant microcirculatory patterns in ciliary body and choroidal melanomas
94.			Marker enzymes of rat chemical hepatocarcinogenesis in human liver tumors
95.			M-ESLON (retard release morphine sulphate capsules) for pain control in cancer patients
96.			Modification of acute and chronic liver damage by thiazolidine compounds
97.			Modulation of multidrug resistance in cancer by immunosuppressive agents
98.			Molecular cancer vaccines: tumor therapy using antigen-specific immunizations
99.			Molecular chaperones in the etiology and therapy of cancer
100.			Molecular events as targets of anticancer drug therapy

Mind kijelölve: